Here are relevant reports on : point-of-care-testing-POCT-market
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Cardiac Marker Testing Market by Product, Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Technology (Chemiluminescence, ELISA), Indication (MI, CHF, Atherosclerosis), Assay Format (Singleplex, Multiplex), Point of Testing - Global Forecast to 2031
The global cardiac market testing market is projected to reach USD 9.06 billion by 2031, growing at a CAGR of 10.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
Global ASEAN point of care diagnostics market valued at $1.05B in 2024, reached $1.08B in 2025, and is projected to grow at a robust 4.7% CAGR, hitting $1.36B by 2030. The increasing incidence of chronic conditions, especially diabetes, generates the demand for regular monitoring and early detection, boosting the need for rapid & accurate POC testing solutions
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharma, Cosmetics & Personal Care, Medical Devices, Consumer Products) and Region - Global Forecast to 2027
The global efficacy testing market growth is primed to transition from $315 million in 2022 to $423 million by 2027, showcasing a strong CAGR of 6.1%. Factors such as regulations for pharmaceutical and cosmetic products addressing the safety of the products are expected to drive the growth of the global market for efficacy testing in the coming years.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Hospital Filtration Market by Type (Point of Use Filters, Inline Filters, Standalone Filtration Units, Disposable Filters), Process Type, Application (Hospital Facilities, Laboratories, Patient Care Equipment) and Region - Global Forecast to 2030
The hospital filtration market is expected to grow from USD 2.10 billion in 2024 to USD 3.19 billion by 2030, at a CAGR of 7.2% during the forecast period. To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the hospital filtration market. These includes Danaher (US), Veolia (France), Pentair (US), Merck KgaA (Germany), Daikin Industries (Japan), Camfil (Sweden), Freudenberg Technologies (Germany), Solventum (US), Sartorius AG (Germany), and Parker Hannifin Corp. (US)
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030
The North America Blood Glucose Monitoring Devices market, valued at USD 6.02 billion in 2024, stood at USD 6.52 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of USD 9.93 billion by the end of the period. The North America blood glucose monitoring devices market is experiencing steady growth, driven by several key factors. Rising diabetes prevalence, fueled by aging populations, urbanization, and lifestyle changes, is increasing demand for effective self-monitoring solutions.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Crowdsourced Testing Market by Testing Type (Performance Testing, Functionality Testing, Usability Testing, Localization Testing, and Security Testing), Platform, Organization Size, Deployment Mode, Vertical and Region - Global Forecast to 2027
The global Crowdsourced testing market size is expected to reach USD 2.5 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 9.4 % during the forecast period. The Crowdsourced testing market vendors have implemented various types of organic and inorganic growth strategies, such as new product launches, product upgradations, partnerships and agreements, business expansions, and mergers and acquisitions to strengthen their offerings in the market. The major vendors in the global Crowdsourced testing market include Qualitest (US), Nomura Research Institute, Ltd. (Japan), Infosys Limited (India), Cigniti Technologies (US), EPAM Systems, Inc. (US), Flatworld Solutions Pvt. Ltd. (India), Test Yantra Software Solutions (India), Cobalt Labs Inc. (US), Bugcrowd Inc. (US), Qualitrix (India), Global App Testing (UK), Applause App Quality, Inc. (US), Synack (US), Testbirds (Germany), Rainforest QA, Inc. (US), Digivante Ltd (UK), Testlio Inc. (US), Crowdsprint (Australia), MyCrowd (US), Ubertesters Inc. (US), QA Mentor, Inc. (US), Crowd4Test (India), TestUnity (India), usabitest.com (Nigeria), Stardust testing (Canada), and ImpactQA (US). The study includes an in-depth competitive analysis of these key players in the Crowdsourced testing market with their company profiles, recent developments, and key market strategies.
- Published: March 2022
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
